[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$ft0HIXLxIcjnJW04hBh766Ew4M-5bqqDGLWIpLUksl8A":8,"$fq3S4vlmida5u-cTjBs7vRKE9rE1p3JC5wfilFcPFyuA":55,"$fgvhahj6VobZ1hY2sJGvtjPlINpLrSlbGyit4vZljhMk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66823,863402,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//0Rvlsm1tdkSbq5L99bjhchaojzwJ5kCw.png","华晓萍","浙江大学医学院附属妇产科医院","妇科","主治医师",94,0,"复发性子宫内膜癌新选择：贝伐珠单抗安全用药指南","","https://ystcdn.venuertc.com/venue/AI/d37fef74-9555-429d-8bdd-71c6d3358e1a.jpg","\u003Cdiv class=\"bev-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"bev-material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">复发性子宫内膜癌新选择：贝伐珠单抗安全用药指南\u003C/h1>\n\n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">认识贝伐珠单抗：一种常用的靶向药物 💊\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      说起贝伐珠单抗（Bevacizumab），不少朋友已经在新闻或者医生那里听过。作为一种新型靶向药物，它常被用于多种肿瘤治疗中。那贝伐珠单抗到底有什么独特之处？用药前后需要注意哪些细节？本文将从7个常见问题出发，详细拆解贝伐珠单抗的正确用法、注意事项及安全风险，帮你用药不迷路。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔬 01. 贝伐珠单抗的成分、规格与剂型\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      贝伐珠单抗是一种重组人源化单克隆抗体，通用名Bevacizumab。\u003Cbr>\n      \u003Cstrong>剂型特点：\u003C/strong> 目前市面主要为注射用浓溶液，多为100mg/4ml或400mg/16ml规格，需由医护人员静脉滴注。\u003Cbr>\n      \u003Cstrong>成分说明：\u003C/strong> 其活性成分通过基因工程制备，专门结合并阻挡血管内皮生长因子（VEGF），属于VEGF抑制剂。\u003Cbr>\n      \u003Cstrong>包装与保存：\u003C/strong> 贝伐珠单抗均为瓶装粉针或已配好溶液的玻璃瓶，无口服制剂，贯彻需要专业操作的原则。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🧬 02. 药物作用机制：针对血管“断粮”\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      其实，贝伐珠单抗的核心机制就是靶向并抑制血管内皮生长因子（VEGF），这样能阻止新血管的生成，相当于让肿瘤\"断粮\"。具体原理在于药物直接与体内VEGF结合，防止它与血管内皮细胞受体结合，减少新血管的形成，从而限制肿瘤生长和扩展。不仅切断营养供应，也能减轻肿瘤周围水肿和相关并发问题。\u003Cbr>\n      \u003Cspan class=\"bev-small-text\">（参考：Ferrara et al., 2004, \"Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy\", Biochemical and Biophysical Research Communications）\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🕰️ 03. 具体用法用量：安全滴注很关键\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      \u003Cstrong>正确用药方式：\u003C/strong> 贝伐珠单抗需在医院静脉滴注（绝不可自行口服或皮下注射）。每次用量按体重计算，由医生根据体表面积和治疗方案调整，常见剂量为15mg/kg，每3周滴注一次。\u003Cbr>\n      \u003Cspan class=\"bev-emphasize\">用药顺序：\u003C/span> 通常先给予化疗药物，随后滴注贝伐珠单抗。每次滴注时间建议不低于90分钟，严禁快滴，以减少不良反应。\u003Cbr>\n      \u003Cspan class=\"bev-point\">正确做法：\u003C/span>\n      \u003Cul>\n        \u003Cli>务必于专业医疗人员监护下用药\u003C/li>\n        \u003Cli>首次用药宜密切观察，尤其前15分钟\u003C/li>\n        \u003Cli>治疗期间严密监测血压、尿常规、蛋白尿、凝血功能等指标\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">💡 04. 特殊人群用药调整与注意 🔖\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      贝伐珠单抗的用药剂量及频率有时需根据患者具体情况作出调整。\u003Cbr>\n      \u003Cstrong>老年患者：\u003C/strong> 65岁以上患者使用本品时须严密关注血压变化和肾功能。\u003Cbr>\n      \u003Cstrong>儿童：\u003C/strong> 目前缺乏足够安全性和有效性数据，儿童用药须在专科医生严格指导下使用。\u003Cbr>\n      \u003Cstrong>孕妇及哺乳期：\u003C/strong>\n      药物可能影响胎儿血管发育，孕妇及哺乳期妇女通常禁用，如有必要须权衡利弊，详细咨询医生。\n      \u003Cbr>\n      \u003Cstrong>肝肾功能不全：\u003C/strong>\n      中重度肝肾功能受损人群，用药需评估风险，必要时调整剂量和监测频率。\n      \u003Cbr>\n      \u003Cspan class=\"bev-point\">临床用药案例：\u003C/span>“有位53岁女性患者在专业医生评估下，配合辅助药物与化疗进行联合用药，并根据体重调整贝伐珠单抗用量，实现靶向治疗与安全监测双重保障。”\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📋 05. 药物相互作用需警惕！\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      贝伐珠单抗与其他药物合用时，存在一定相互作用风险，主要需警惕以下情形：\u003Cbr>\n      \u003Cspan class=\"bev-emphasize\">禁忌联合：\u003C/span>\n      \u003Cul>\n        \u003Cli>同用阿柏西普、雷珠单抗等其他VEGF抑制剂时，有风险明显增加。\u003C/li>\n        \u003Cli>与高剂量含铂化疗药物并用，不良反应（如蛋白尿、血压升高）发生率升高。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-point\">正确做法：\u003C/span>\n      \u003Cul>\n        \u003Cli>化疗联合时应遵医嘱按顺序使用\u003C/li>\n        \u003Cli>合用降压药、抗凝药等时，需告知医生以避免不良反应叠加\u003C/li>\n        \u003Cli>遇到需要长期慢性病服药者，务必进行用药史梳理，主动报告医生\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-small-text\">\n        详见：Gordon, M. S., & Cunningham, D. (2005). Managing patients treated with bevacizumab combination therapy. The Oncologist, 10(6), 437-446.\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">⚠️ 06. 不良反应预警及处理方法\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      贝伐珠单抗安全性总体良好，但部分不良反应值得高度重视。\u003Cbr>\n      \u003Cspan class=\"bev-emphasize\">常见不良反应\u003C/span>（据多项国际研究，发生率约16%-40%不等）：\u003Cbr>\n      \u003Cul>\n        \u003Cli>高血压（约16%-34%，需定期监测血压）\u003C/li>\n        \u003Cli>蛋白尿或肾功能异常（2%-36%）\u003C/li>\n        \u003Cli>出血倾向：包括鼻出血、牙龈出血等\u003C/li>\n        \u003Cli>手足麻木、乏力、头晕等神经系统表现\u003C/li>\n        \u003Cli>少见但严重：胃肠穿孔、伤口愈合延迟\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-point\">处理建议：\u003C/span>\n      \u003Cul>\n        \u003Cli>首次用药出现全身不适或呼吸急促，需立即联系医护人员\u003C/li>\n        \u003Cli>血压明显升高者，按时服降压药，并定期复查\u003C/li>\n        \u003Cli>出现蛋白尿或水肿要及时监测并报告医生\u003C/li>\n        \u003Cli>有出血风险的患者如出现明显出血立即停药并就医\u003C/li>\n        \u003Cli>用药期间切勿同时进行大手术或创伤性操作，以防影响伤口愈合\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-small-text\">数据来源：Hurwitz H, Fehrenbacher L, et al. \"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer\". N Engl J Med. 2004;350(23):2335-2342.\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📦 07. 储存方法与有效期⏳\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      贝伐珠单抗的保存要求严格：\u003Cbr>\n      \u003Cul>\n        \u003Cli>药品应放在2–8℃环境下保存，避免冷冻\u003C/li>\n        \u003Cli>需避光密封置于原包装内，不宜与其他药物混放\u003C/li>\n        \u003Cli>如已稀释，仅能在2–8℃冷藏保存8小时内使用，超时建议丢弃\u003C/li>\n        \u003Cli>过期或颜色异常严禁使用，剩余药物需按医疗废弃物规范处理\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-point\">参考说明书要求操作，如家中有药瓶需上锁远离儿童\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🥼 08. 避免漏服与过量：处理方式怎么做？\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      由于贝伐珠单抗为静脉滴注用药，一般由医院专业人员操作，几乎不会出现漏服问题。\u003Cbr>\n      \u003Cspan class=\"bev-emphasize\">万一漏滴：\u003C/span> 应联系医务人员补做相关评估，避免随意自行调整治疗周期。\u003Cbr>\n      \u003Cspan class=\"bev-emphasize\">如发生过量：\u003C/span>\n      虽不常见，但高剂量有加重不良反应风险，如高血压、蛋白尿及严重出血。应立即就医处理并监控血压及肾功能等，多数情况会采取对症支持治疗措施。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🌟 09. 用药期间的自我管理方法\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      作为一款高效的生物制剂，用药过程中的自我管理同样关键：\u003Cbr>\n      \u003Cul>\n        \u003Cli>记录每次用药时间、剂量和感受，便于医院复诊和监控副反应\u003C/li>\n        \u003Cli>定期复查：包括体重、血压、尿常规、肝肾功能等\u003C/li>\n        \u003Cli>合理安排饮食，均衡摄入蛋白质、维生素，保持体重稳定\u003C/li>\n        \u003Cli>如有不适症状（如高血压、异常出血、浮肿），应及时与医生联系，切不可拖延\u003C/li>\n        \u003Cli>坚持按医嘱定期治疗，不随意中断药物，不自行减少剂量\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"bev-point\">\n        便捷小贴士：治疗期间身心压力大时可以寻求亲友或心理服务的支持，帮助减轻焦虑。\n      \u003C/span>\n      \u003Cbr>\n      \u003Cspan class=\"bev-small-text\">临床药师建议：与主治医生保持良好沟通，对所有辅助用药、保健药物一并报备，避免药物互动。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📑 10. 真实用药经验分享\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      \u003Cul>\n        \u003Cli>临床有患者在联合贝伐珠单抗治疗过程中，通过规律血压监测和蛋白尿检测，有效控制了副作用发生。\u003C/li>\n        \u003Cli>有患者服药时主动向医生报告使用的降压药与保肝药，医生及时调整了辅助药物，顺利完成治疗周期。\u003C/li>\n      \u003C/ul>\n      这些真实用药细节，印证了安全用药、积极监测、密切沟通的重要性。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"bev-section\">\n    \u003Cdiv class=\"bev-bg-subtle\">\n      \u003Ch2 class=\"bev-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔍 参考文献\u003C/h2>\n    \u003C/div>\n    \u003Cdiv class=\"bev-text-body\">\n      \u003Cul class=\"bev-reference-list\">\n        \u003Cli>Ferrara, N., Hillan, K. J., Gerber, H. P., & Novotny, W. (2004). Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. \u003Cem>Biochemical and Biophysical Research Communications, 333(2), 328-335\u003C/em>.\u003C/li>\n        \u003Cli>Gordon, M. S., & Cunningham, D. (2005). Managing patients treated with bevacizumab combination therapy. \u003Cem>The Oncologist, 10(6), 437-446\u003C/em>.\u003C/li>\n        \u003Cli>Hurwitz H, Fehrenbacher L, et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. \u003Cem>N Engl J Med. 350(23):2335-2342\u003C/em>.\u003C/li>\u003C/ul>\u003C/div>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.bev-material-container {\n  background: #fbfcfd;\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  color: #253350;\n  padding: 32px 16px 32px 16px;\n  max-width: 860px;\n  margin: 48px auto;\n  border-radius: 14px;\n  box-shadow: 0 2px 16px 0 rgba(100, 120, 125, 0.12), 0 1.5px 8px 0 rgba(100, 120, 125, 0.08);\n}\n.bev-material-title {\n  font-size: 2.3rem;\n  font-weight: 700;\n  color: #2467b1;\n  text-shadow: 0 2px 8px rgba(36,103,177,0.07);\n  border-left: 8px solid #6bb8ff;\n  padding-left: 18px;\n  margin-bottom: 30px;\n  margin-top: 0;\n}\n.bev-section {\n  margin-bottom: 38px;\n}\n.bev-bg-subtle {\n  background: linear-gradient(90deg, #e4edfa 0%, #f8fafc 100%);\n  border-radius: 8px 8px 0 0;\n  padding: 18px 28px 8px 18px;\n  margin-bottom: 0;\n  min-height: 32px;\n}\n.bev-section-title {\n  font-size: 1.23rem;\n  color: #264573;\n  font-weight: 600;\n  margin: 0;\n  padding: 0;\n  letter-spacing: 0.03em;\n}\n.bev-text-body {\n  background: #fff;\n  font-size: 1.06rem;\n  color: #253350;\n  line-height: 1.9;\n  padding: 18px 22px 16px 22px;\n  border-radius: 0 0 8px 8px;\n  box-shadow: 0 1px 2.5px 0 rgba(36,103,177,0.04);\n  margin: 0;\n}\n\n.bev-text-body ul {\n  margin: 14px 0 14px 26px;\n  padding: 0;\n}\n.bev-text-body li {\n  margin-bottom: 6px;\n  line-height: 1.7;\n}\n.bev-point {\n  display: inline-block;\n  color: #1667be;\n  font-weight: 600;\n  margin-top: 10px;\n}\n.bev-emphasize {\n  color: #d04835;\n  font-weight: 700;\n  margin-right: 4px;\n}\n.bev-small-text {\n  display: block;\n  font-size: 0.98em;\n  color: #5370a3;\n  margin-top: 10px;\n  line-height: 1.7;\n}\n.bev-reference-list li em {\n  color: #6678c2;\n  font-style: normal;\n}\n@media (max-width: 750px) {\n  .bev-material-container {\n    padding: 13px 2.5vw 27px 2.5vw;\n    margin: 18px auto;\n  }\n  .bev-material-title {\n    font-size: 1.55rem;\n    border-left-width: 5px;\n    padding-left: 12px;\n    margin-bottom: 18px;\n  }\n  .bev-section-title {\n    font-size: 1.08rem;\n    padding-right: 4px;\n    margin-right: 0;\n  }\n  .bev-bg-subtle {\n    padding: 12px 11px 6px 10px;\n    border-radius: 7px 7px 0 0;\n    min-height: 28px;\n  }\n  .bev-text-body {\n    font-size: 0.99rem;\n    padding: 12px 8px 12px 10px;\n    border-radius: 0 0 7px 7px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"bev-material-container\">\n  \u003Ch1 id=\"material_title\" class=\"bev-material-title\" style=\"col",502,"2025-09-19 11:03:13","贝伐珠单抗, 靶向药物, 子宫内膜癌, 用药指南, 不良反应, 安全用药, 肾功能, 高血压","了解贝伐珠单抗的安全用药方法与注意事项，帮助患者有效监测副作用，合理使用靶向治疗药物，提升治疗体验。","2025-10-13 19:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]